Insider filing · NTRA
Matthew Rabinowitz
EXECUTIVE CHAIRMAN
profile →
Natera, Inc.
NTRA · Healthcare · 219 filings in 24 months
ticker →
Matthew Rabinowitz sold $9.0M of Natera (NTRA)
Executed Sep 18 2025, disclosed Sep 19 2025, 1 day later.
Value, as filed
$9.0M
50,000 sh across 4 lots
Executed
Sep 18 2025
the trade date, as filed
Disclosed
Sep 19 2025
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MRMatthew Rabinowitz (EXECUTIVE CHAIRMAN) filed 12 Form 4 reports in the trailing twelve months (0 purchases, 12 sales), most often in Natera, Inc. (NTRA). The largest single filing was $38.1M of NTRA (199,246 sh across 19 lots, as filed), executed Mar 12.
The name
NTRAHealthcare · Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Matthew Rabinowitz in NTRA
NTRASALE
Natera, Inc.
$34.8M102,000 sh across 29 lots
Exec Sep 14
Filed Sep 16 · 9:35 PM ET NTRASALE Natera, Inc. $16.4M
50,000 sh across 6 lots
Exec Sep 11
Filed Sep 11 · 9:35 PM ET NTRASALE Natera, Inc. $642K
2,000 sh × $320.90
Exec Aug 7
Filed Aug 7 · 9:35 PM ET NTRASALE Natera, Inc. $196K
731 sh × $267.99
Exec Aug 3
Filed Aug 5 · 9:35 PM ET NTRASALE Natera, Inc. $448K
1,718 sh × $260.49
Exec Jul 27
Filed Jul 29 · 9:35 PM ET NTRASALE Natera, Inc. $280K
1,000 sh × $280.00
Exec Jul 6
Filed Jul 8 · 9:05 PM ET NTRASALE Natera, Inc. $21.4M
99,600 sh across 20 lots
Exec Jun 12
Filed Jun 16 · 5:30 PM ET NTRASALE Natera, Inc. $1.6M
7,708 sh across 5 lots
Exec May 4
Filed May 6 · 5:30 PM ET